Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
30 results
D2.33 - Complex occupational allergic contact dermatitis: polysensitization in a worker exposed to metals, adhesives, and plastics
D2.34 - Pediatric allergic contact cheilitis associated with propolis sensitization
D2.35 - Occupational Protein Contact Dermatitis to Latex Compromising Fitness for Work in a Nurse
D2.37 - Occupational Allergic Dermatoses of the Face: Allergen Distribution and Work-Related Outcomes
D2.38 - Occupational Exposure to Propolis: A Rare Cause of Allergic Contact Dermatitis in Textile Workers
D2.39 - Occupational Contact Dermatitis with Polysensitization to Metals: Challenges for Work Fitness and Prevention
D2.40 - Occupational allergic contact dermatitis to metals: clinical features and impact on work fitness
D2.41 - Production of recombinant Cuc ma 5: A Step Towards Molecular Diagnosis of Pumpkin Seed Allergy
D2.42 - Evaluation of User Experience with a Skin Prick Automated Test (SPAT) Device compared to a Manual Skin Prick Test (SPT) in Pediatric Patients
D2.30 - A Case of Kimura’s Disease with Atypical Presentation and Novel Genetic Findings
D2.31 - A Case of Acquired C1 Inhibitor Deficiency Angioedema with Anti-C1q Antibodies in Systemic Lupus Erythematosus and Negative Exome Sequencing
D2.32 - A Positive Drug Challenge to Amoxicillin and Clavulanate (AMX) in a Child, Six Years After the Initial Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE)
D3.157 - Clinical characteristics and associated factors of persistent asthma in preschool children with wheezing in a tropical region
D3.158 - Dupilumab Response in a Patient with Severe Asthma Refractory to Anti-IL5 Therapy: A Case Report
D3.165 - Phase 1 study of CDX-622, a bispecific antibody targeting TSLP and mast cells via stem cell factor
D3.153 - Add-on Dupilumab therapy significantly reduces severe asthma exacerbations and emergency visits in patients with severe persistent asthma requiring oral corticosteroids for maintenance therapy: our experience in Réunion Island
D3.154 - Trends in Bronchial Asthma Incidence in Crimea: Analysis from 2017-2024 with Age-Specific Insights
D3.155 - Th2–Th17 immune shift following dupilumab therapy
D3.156 - Pulmonary embolism in a young asthma patient
D3.159 - Early Bronchodilator Response in Asthma: When Is Testing Really Necessary?
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download